Cita APA

Lim, Y., Ahn, S., Seto, W., Ning, Q., Agarwal, K., Chan, H. L. Y., & Buti Ferret, M. (2023). Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B.

Citación estilo Chicago

Lim, Young-Suk, Sang-Hoon Ahn, Wai-Kay Seto, Qin Ning, Kosh Agarwal, Henry Lik Yuen Chan, y Maria Buti Ferret. Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate Reduce Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. 2023.

Cita MLA

Lim, Young-Suk, et al. Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate Reduce Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. 2023.